Company Filing History:
3 out of 192 
2 out of 247 
1 out of 377 
Years Active: 1990-2001
Title: Claude Garret: Innovator in Neurokinin Research
Introduction
Claude Garret is a notable inventor based in Fontenay sous Bois, France. He has made significant contributions to the field of pharmacology, particularly in the area of neurokinin receptors. With a total of 6 patents to his name, Garret's work has had a profound impact on the treatment of various diseases.
Latest Patents
One of Garret's latest patents focuses on a synergizing combination that has an antagonist effect on NKI and NK2 receptors. This innovative approach involves synergizing associations characterized by at least one product with antagonist activity on NK1 receptors and at least one product with antagonist activity on NK2 receptors. These associations are particularly useful in treating diseases involving substance P and/or neurokinin A. Another significant patent involves the use of phenothiazine derivatives in the treatment of ischemia.
Career Highlights
Throughout his career, Claude Garret has worked with prominent companies such as Rhone-Poulenc Santé and Rhone-Poulenc Rorer S.A. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.
Collaborations
Garret has collaborated with esteemed colleagues, including Claude Guyon and Bernard Plau. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Claude Garret's contributions to neurokinin research and his innovative patents highlight his importance in the field of pharmacology. His work continues to influence the development of treatments for various diseases, showcasing the impact of dedicated inventors in the medical industry.